sulfaphenazole has been researched along with cyclin d1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Busse, R; Fisslthaler, B; Fleming, I; Michaelis, UR; Potente, M | 1 |
1 other study(ies) available for sulfaphenazole and cyclin d1
Article | Year |
---|---|
Cytochrome P450 2C9-induced endothelial cell proliferation involves induction of mitogen-activated protein (MAP) kinase phosphatase-1, inhibition of the c-Jun N-terminal kinase, and up-regulation of cyclin D1.
Topics: 8,11,14-Eicosatrienoic Acid; Aryl Hydrocarbon Hydroxylases; Cell Cycle Proteins; Cell Division; Cells, Cultured; Culture Media, Serum-Free; Cyclin D1; Cytochrome P-450 Enzyme System; Dual Specificity Phosphatase 1; Endothelium, Vascular; Enzyme Induction; Gene Expression Regulation; Humans; Hydrogen Peroxide; Immediate-Early Proteins; JNK Mitogen-Activated Protein Kinases; Kinetics; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphoprotein Phosphatases; Protein Phosphatase 1; Protein Tyrosine Phosphatases; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Sulfaphenazole; Time Factors; Transfection; Umbilical Veins | 2002 |